1,3,4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities
作者:Marwa Ali A. Fathi、Amer Ali Abd El-Hafeez、Dalia Abdelhamid、Samar H. Abbas、Monica M. Montano、Mohamed Abdel-Aziz
DOI:10.1016/j.bioorg.2018.11.032
日期:2019.3
A new series of 1,3,4-oxadiazole/chalcone hybrids was designed, synthesized, identified with different spectroscopic techniques and biologically evaluated as inhibitors of EGFR, Src, and IL-6. The synthesized compounds showed promising anticancer activity, particularly against leukemia, with 8v being the most potent. The synthesized compounds exhibited strong to moderate cytotoxic activities against K-562, KG-1a, and Jurkat leukemia cell lines in MTT assays. Compound 8v showed the strongest cytotoxic activity with IC50 of 1.95 mu M, 2.36 mu M and 3.45 mu M against K-562, Jurkat and KG-1a leukemia cell lines, respectively. Moreover; the synthesized compounds inhibited EGFR, Src, and IL-6. Compound 8v was most effective at inhibiting EGFR (IC50, = 0.24 mu M), Src (IC50 = 0.96 mu M), and IL-6 (% of control = 20%). Additionally, most of the compounds decreased STAT3 activation.